Clinical Trial

A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment

Name: A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment — clinical trial record (NCT07708181)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the efficacy and safety of recombinant anti-interleukin-1β humanized monoclonal antibody injection in Chinese gout participants Initiating Urate-Lowering Treatment

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-12.

Trial Details

NCT Number	NCT07708181
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Gout Arthritis
Enrollment	200 participants
Start Date	2026-08-02
Primary Completion	2027-08-11 (estimated)
Study Completion	2028-04-19 (estimated)
Updated on ClinicalTrials.gov	2026-07-20